跳至主要内容
临床试验/NCT06248294
NCT06248294尚未招募不适用

PRogression Of bicuSPid-rElated aoRtOpathy in Patients Undergoing Transcatheter Aortic Valve Implantation: The PROSPERO-TAVI Multi Center, International Registry

University of Catania1 个研究点 分布在 1 个国家目标入组 300 人开始时间: 2024年2月1日最近更新:
适应症

试验速览

阶段
不适用
状态
尚未招募
入组人数
300
试验地点
1
主要终点
Absolute difference in maximum aortic diameters at multiple levels of ascending aorta

研究概览

简要总结

Transcatheter aortic valve implantation (TAVI) is being offered to younger patients affected by severe aortic stenosis as an alternative to surgery. Although historically excluded from the main randomized clinical trials, patients with native bicuspid aortic valve (BAV) are commonly treated in daily TAVI practice. Indeed, several observational studies reported similar outcomes of TAVI in BAV patients compared to tricuspid aortic valve (TAV) patients. Notably, BAV is frequently associated with aortic dilatation (20% to 84% of BAV patients). Surgical patients usually undergo concomitant aortic root replacement if aortic diameter exceed 50 mm (5). TAVI patients do not undergo treatment of the concomitant aortopathy, but currently there is a paucity of data regarding the progression of the aortopathy after AS treatment (6,7).

The main aim of this ambispective, multicenter study is to evaluate the progression of the bicuspid valve-associated aortopathy in patients undergoing TAVI by computed tomography angiography (CTA) assessment at follow-up.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Other

入排标准

性别
All
接受健康志愿者

入选标准

  • Patients undergoing TAVI with native BAV from January 2018 to December 2019

排除标准

  • Patients undergoing TAVI without native BAV
  • Patients receiving first generation TAVI device
  • Patients undergoing TAVI before January 2018 or after December 2019

结局指标

主要结局

Absolute difference in maximum aortic diameters at multiple levels of ascending aorta

时间窗: 5 years

Measurements of maximum aortic diameters at follow-up CTA assessment will be compared with values at pre-TAVI CTA assessment

次要结局

  • Bioprosthesis dysfunction (HALT or RLM at 4-D CTA assessment)(5 years)
  • Death, stroke or rehospitalization for heart failure(5 years)
  • Aortic events leading to urgent intervention or elective aortic root replacement(5 years)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Giuliano Costa

Principal Investigator

University of Catania

研究点 (1)

Loading locations...

相似试验

PRogression Of bicuSPid-rElated aoRtOpathy in... | 临床试验